In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Zimmer Biomet Holdings Inc (NYSE: ZBH) closed at $98.89 in the last session, up 0.40% from day before closing price of $98.5. In other words, the price has increased by $0.40 from its previous closing price. On the day, 1.19 million shares were traded. ZBH stock price reached its highest trading level at $99.3286 during the session, while it also had its lowest trading level at $96.055.
Ratios:
We take a closer look at ZBH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 35.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.81. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.87. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.54.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rothschild & Co Redburn on September 18, 2025, initiated with a Buy rating and assigned the stock a target price of $130.
On July 15, 2025, Roth Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $135.
JP Morgan Upgraded its Neutral to Overweight on December 17, 2024, whereas the target price for the stock was revised from $125 to $128.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 11 ’25 when Yi Sang sold 1,200 shares for $103.58 per share. The transaction valued at 124,302 led to the insider holds 18,584 shares of the business.
Yi Sang bought 1,200 shares of ZBH for $124,302 on Sep 11 ’25. On Sep 08 ’25, another insider, Winkler Lori, who serves as the SVP and CHRO of the company, sold 1,500 shares for $104.15 each. As a result, the insider received 156,225 and left with 6,833 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZBH now has a Market Capitalization of 19589711872 and an Enterprise Value of 26763612160. As of this moment, Zimmer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.08, and their Forward P/E ratio for the next fiscal year is 11.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.50 while its Price-to-Book (P/B) ratio in mrq is 1.56. Its current Enterprise Value per Revenue stands at 3.416 whereas that against EBITDA is 10.339.
Stock Price History:
The Beta on a monthly basis for ZBH is 0.67, which has changed by -0.054611742 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, ZBH has reached a high of $114.72, while it has fallen to a 52-week low of $89.22. The 50-Day Moving Average of the stock is -1.70%, while the 200-Day Moving Average is calculated to be -2.29%.
Shares Statistics:
According to the various share statistics, ZBH traded on average about 1.59M shares per day over the past 3-months and 1561080 shares per day over the past 10 days. A total of 197.90M shares are outstanding, with a floating share count of 197.82M. Insiders hold about 0.14% of the company’s shares, while institutions hold 98.43% stake in the company. Shares short for ZBH as of 1757894400 were 6572390 with a Short Ratio of 4.13, compared to 1755216000 on 6961467. Therefore, it implies a Short% of Shares Outstanding of 6572390 and a Short% of Float of 3.8.
Dividends & Splits
The forward annual dividend rate for ZBH is 1.20, which was 0.96 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.009746193. The stock’s 5-year Average Dividend Yield is 0.79. The current Payout Ratio is 21.66% for ZBH, which recently paid a dividend on 2025-09-30 with an ex-dividend date of 2025-09-30. Stock splits for the company last occurred on 2022-03-01 when the company split stock in a 103:100 ratio.
Earnings Estimates
. The current rating of Zimmer Biomet Holdings Inc (ZBH) reflects the combined expertise of 24.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $2.4, with high estimates of $2.49 and low estimates of $2.26.
Analysts are recommending an EPS of between $8.24 and $7.93 for the fiscal current year, implying an average EPS of $8.15. EPS for the following year is $8.56, with 27.0 analysts recommending between $9.01 and $8.31.
Revenue Estimates
According to 22 analysts,. The current quarter’s revenue is expected to be $2.01B. It ranges from a high estimate of $2.03B to a low estimate of $1.98B. As of. The current estimate, Zimmer Biomet Holdings Inc’s year-ago sales were $1.82BFor the next quarter, 22 analysts are estimating revenue of $2.23B. There is a high estimate of $2.25B for the next quarter, whereas the lowest estimate is $2.21B.
A total of 26 analysts have provided revenue estimates for ZBH’s current fiscal year. The highest revenue estimate was $8.25B, while the lowest revenue estimate was $8.11B, resulting in an average revenue estimate of $8.22B. In the same quarter a year ago, actual revenue was $7.68BBased on 25 analysts’ estimates, the company’s revenue will be $8.68B in the next fiscal year. The high estimate is $8.83B and the low estimate is $8.29B.
